10/3/2022  10:10:00 PM Chg. -0.450 Volume Bid10/3/2022 Ask10/3/2022 Market Capitalization Dividend Y. P/E Ratio
15.750CHF -2.78% -
Turnover: -
14.050Bid Size: 300 17.500Ask Size: 700 157.85 mill.CHF - -

Business description

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. The Company operates in Israel, Germany, Indien and the United States in one business segment, Telemedicine services. SHL was founded in 1987 by Yoram Alroy and Elon Shalev.
 

Management board & Supervisory board

CEO
Erez Nachtomy
Management board
Linus Drop, Yoni Dagan, Yossi Vadnagra
Supervisory board
Yariv Alroy, David Salton, Devorah Kimhi, Dr. Amir Lerman, Erez Alroy, Erez Nachtomy, Yehoshua Abramovich
 

Company data

Name: SHL TeleMedicine Ltd.
Address: 90 Yigal Alon St.,IL-67891 Tel Aviv
Phone: +972-3-5612212
Fax: +972-3-6242414
E-mail: -
Internet: www.shl-telemedicine.com/
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 29.43%
IPO date: -

Investor relations

Name: Martin Meier-Pfister
IR phone: +41-43-2448140
IR Fax: -
IR e-mail: martin.meier-pfister@irfcom.ch

Main Shareholders

Cai Mengke and Shen Kun
 
41.27%
Freefloat
 
29.43%
Alroy Group
 
17.33%
More Provident Funds
 
6.18%
Value Base Group
 
5.79%